Valuation: Jerusalem Pharmaceuticals Co. Ltd.

Market Cap 130M 111M 104M 95.01M 178M 12.4B 181M 1.23B 478M 6.23B 487M 476M 20.59B P/E 2024
13.7x
P/E 2025 8.13x
Enterprise Value 119M 102M 95.06M 87.03M 163M 11.36B 166M 1.12B 438M 5.7B 446M 436M 18.86B EV / Sales 2024
1.47x
EV / Sales 2025 1.47x
Free-Float
35.74%
Yield 2024
2.09%
Yield 2025 3.26%
1 day+2.86%
Current month-4.00%
1 month-4.00%
3 months-2.96%
6 months+55.51%
Current year+56.52%
1 week 3.5
Extreme 3.5
3.6
1 month 3.5
Extreme 3.5
3.75
Current year 2.28
Extreme 2.285
4
1 year 1.9
Extreme 1.9
4
3 years 1.74
Extreme 1.745
4
5 years 1.32
Extreme 1.325
4
10 years 0.8
Extreme 0.795
4
Manager TitleAgeSince
Chief Executive Officer - 2013-06-30
Director of Finance/CFO - 2020-02-29
Chief Tech/Sci/R&D Officer - 1988-12-31
Director TitleAgeSince
Chairman 91 -
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+2.86%0.00%+73.49%+88.48% 130M
-0.08%-1.53%+16.49%+67.63% 47.74B
-3.21%-1.93%+51.06%+125.79% 41.7B
-0.40%-1.82%-7.37%+15.84% 12.14B
+1.11%-4.05%+13.90%+72.88% 11.55B
0.00%0.00%+30.00%+147.62% 9.18B
-0.39%+0.62%+19.93%+39.54% 7.54B
-1.35%+1.26%+44.30%-11.69% 7.35B
-0.64%-0.09%+20.47%+202.52% 6.88B
-5.36%-8.72%-34.95%+17.39% 5.72B
Average -0.75%-1.29%+22.73%+76.60% 14.99B
Weighted average by Cap. -1.18%-0.77%+24.60%+83.90%

Financials

2024 2025
Net sales 39.82M 34.1M 31.89M 29.19M 54.81M 3.81B 55.55M 377M 147M 1.91B 150M 146M 6.33B 48.95M 41.91M 39.2M 35.88M 67.36M 4.68B 68.27M 463M 181M 2.35B 184M 180M 7.78B
Net income 5.04M 4.31M 4.03M 3.69M 6.93M 482M 7.03M 47.67M 18.58M 242M 18.91M 18.5M 800M 10.18M 8.72M 8.16M 7.47M 14.01M 974M 14.2M 96.35M 37.56M 489M 38.23M 37.4M 1.62B
Net Debt -10.32M -8.84M -8.27M -7.57M -14.21M -988M -14.4M -97.67M -38.07M -496M -38.75M -37.91M -1.64B -10.9M -9.33M -8.73M -7.99M -15M -1.04B -15.2M -103M -40.19M -523M -40.91M -40.02M -1.73B
Logo Jerusalem Pharmaceuticals Co. Ltd.
Jerusalem Pharmaceuticals Co Ltd (Al-Quds) is a Palestine-based public shareholding company engaged in the manufacture and trade of pharmaceutical, veterinary, detergent, and cosmetics products. Its product range spans the whole spectrum of ethical pharmaceuticals, as well as over the counter preparations and nutritional supplements. Its Products are presented in different dosage forms such as tablets, capsules, ampoules, granules and powders for suspensions, suspensions, syrups, lotions, powders, suppositories, ovules, creams, ointments, gels, emulgels, ear, eye and nose drops, solutions, mouth rinse and gargles. The Company also produces veterinary products including vials, powders, oral liquids and fodder additives such as multivitamins and multi-minerals. It also manufactures detergents and cosmetics under license from French companies. The Company operates three production facilities include Factory for General Production, Penicillin Factory and Cephalosporin Factory.
Employees
595
Date Price Change Volume
26-08-19 US$3.600 +2.86% 1,200
26-08-18 US$3.500 -2.78% 5,437
26-08-17 US$3.600 0.00% 65
26-08-13 US$3.600 -1.37% 2,286